Paul van der Horst
Presidente presso MOLECURE S.A.
Posizioni attive di Paul van der Horst
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MOLECURE S.A. | Presidente | - | - |
| Direttore/Membro del Consiglio | 14/01/2022 | - | |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Corporate Officer/Principal | - | - |
| Immunetune | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Paul van der Horst
Precedenti posizioni note di Paul van der Horst
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| GALAPAGOS NV | Public Communications Contact | - | 01/04/2021 |
| Corporate Officer/Principal | - | - | |
Van Lanschot Kempen NV (Broker)
 Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Analyst-Equity | - | - |
Formazione di Paul van der Horst
| Erasmus University Rotterdam | Doctorate Degree |
Statistiche
Distribuzione geografica
| Paesi Bassi | 4 |
| Belgio | 3 |
| Polonia | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Analyst-Equity | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| GALAPAGOS NV | Health Technology |
| MOLECURE S.A. | Health Technology |
| Aziende private | 3 |
|---|---|
Van Lanschot Kempen NV (Broker)
Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Finance |
AgomAb Therapeutics NV
AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Commercial Services |
| Immunetune |
- Borsa valori
- Insiders
- Paul van der Horst
- Esperienza
